Chuck Triano

Charles (Chuck) Triano is an accomplished leader in the global investment community with 35 years of industry experience. He most recently served as senior vice president of investor relations at Pfizer since 2008, where he was responsible for all global investor relations functions, as well as operations planning and analysis. Throughout Chuck’s tenure at Pfizer he worked closely with the company’s executive leadership team as Pfizer transformed itself to a pure science-focused Biopharmaceutical company and saw its market value nearly double to over $230 billion during this time. Following his appointment, Pfizer’s investor relations program became consistently ranked as a top program in the pharmaceutical sector with Mr. Triano consistently named as a top investor relations officer in the sector according to Institutional Investor Magazine’s “Best of Corporate America” survey of institutional portfolio managers and analysts.

Prior to Pfizer, Chuck served as the vice president of investor relations at Forest Laboratories, where he initiated the company’s first formal investor relations and corporate communications program, which was twice ranked among the top three programs in the entire healthcare sector by Institutional Investor Magazine. He was also a managing director at The Carson Group, a financial information organization specializing in global shareholder research and capital markets intelligence.

Chuck is a member of the National Investor Relations Institute (NIRI) and has been a speaker at NIRI seminars and conferences as well as a regular guest lecturer at the New York University Masters of Corporate Communications program. He holds a bachelor’s degree from the University of Connecticut and has completed several certificate programs in the areas of finance and investor relations.